News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
250,791 Results
Type
Article (25076)
Company Profile (42)
Press Release (225673)
Multimedia
Podcasts (124)
Webinars (12)
Section
Business (70547)
Career Advice (1388)
Deals (13185)
Drug Delivery (90)
Drug Development (36403)
Employer Resources (169)
FDA (6516)
Job Trends (6708)
News (127387)
Policy (11540)
Tag
Academia (1492)
Academic (1)
Accelerated approval (4)
Adcomms (9)
Allergies (46)
Alliances (19252)
ALS (49)
Alzheimer's disease (689)
Antibody-drug conjugate (ADC) (79)
Approvals (6502)
Artificial intelligence (146)
Autoimmune disease (15)
Automation (4)
Bankruptcy (121)
Best Places to Work (4652)
BIOSECURE Act (15)
Biosimilars (59)
Biotechnology (24)
Bladder cancer (51)
Brain cancer (16)
Breast cancer (128)
Cancer (1011)
Cardiovascular disease (111)
Career advice (1174)
Career pathing (32)
CAR-T (84)
Cell therapy (215)
Cervical cancer (12)
Clinical research (30178)
Collaboration (352)
Compensation (51)
Complete response letters (6)
COVID-19 (1538)
CRISPR (19)
C-suite (116)
Cystic fibrosis (48)
Data (1063)
Decentralized trials (2)
Denatured (45)
Depression (29)
Diabetes (149)
Diagnostics (2460)
Digital health (5)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (72)
Drug pricing (76)
Drug shortages (26)
Duchenne muscular dystrophy (52)
Earnings (19983)
Editorial (37)
Employer branding (23)
Employer resources (142)
Events (29906)
Executive appointments (342)
FDA (7003)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (1)
Funding (343)
Gene editing (46)
Generative AI (17)
Gene therapy (170)
GLP-1 (544)
Government (1932)
Grass and pollen (4)
Guidances (21)
Healthcare (7691)
Huntington's disease (13)
IgA nephropathy (21)
Immunology and inflammation (75)
Indications (10)
Infectious disease (1610)
Inflammatory bowel disease (76)
Inflation Reduction Act (11)
Influenza (15)
Intellectual property (29)
Interviews (229)
IPO (4691)
IRA (35)
Job creations (2158)
Job search strategy (1017)
Kidney cancer (4)
Labor market (40)
Layoffs (280)
Leadership (17)
Legal (2387)
Liver cancer (32)
Lung cancer (149)
Lymphoma (54)
Machine learning (5)
Management (53)
Manufacturing (169)
MASH (48)
Medical device (4778)
Medtech (4781)
Mergers & acquisitions (8686)
Metabolic disorders (443)
Multiple sclerosis (50)
NASH (21)
Neurodegenerative disease (56)
Neuropsychiatric disorders (19)
Neuroscience (990)
NextGen: Class of 2025 (3147)
Non-profit (2157)
Now hiring (36)
Obesity (238)
Opinion (168)
Ovarian cancer (21)
Pain (48)
Pancreatic cancer (32)
Parkinson's disease (80)
Partnered (17)
Patents (68)
Patient recruitment (46)
Peanut (22)
People (24639)
Pharmaceutical (14)
Pharmacy benefit managers (11)
Phase I (7336)
Phase II (13025)
Phase III (12352)
Pipeline (528)
Policy (115)
Postmarket research (1325)
Preclinical (2820)
Press Release (42)
Prostate cancer (54)
Psychedelics (24)
Radiopharmaceuticals (113)
Rare diseases (210)
Real estate (3405)
Recruiting (61)
Regulatory (8182)
Reports (50)
Research institute (1275)
Resumes & cover letters (213)
Rett syndrome (1)
RNA editing (2)
RSV (27)
Schizophrenia (43)
Series A (91)
Series B (44)
Service/supplier (4)
Sickle cell disease (22)
Special edition (18)
Spinal muscular atrophy (81)
Sponsored (19)
Startups (1933)
State (1)
Stomach cancer (8)
Supply chain (34)
Tariffs (23)
The Weekly (77)
Vaccines (454)
Venture capitalists (32)
Weight loss (201)
Women's health (30)
Worklife (18)
Date
Today (38)
Last 7 days (299)
Last 30 days (929)
Last 365 days (12420)
2025 (4042)
2024 (13242)
2023 (14539)
2022 (20820)
2021 (22674)
2020 (21122)
2019 (19513)
2018 (14735)
2017 (13861)
2016 (13404)
2015 (15468)
2014 (10466)
2013 (7678)
2012 (8168)
2011 (8766)
2010 (7321)
Location
Africa (505)
Alabama (15)
Alaska (4)
Arizona (60)
Arkansas (3)
Asia (16237)
Australia (3057)
California (1912)
Canada (568)
China (224)
Colorado (83)
Connecticut (82)
Delaware (52)
Europe (44724)
Florida (297)
Georgia (110)
Idaho (20)
Illinois (228)
India (15)
Indiana (122)
Iowa (8)
Japan (85)
Kansas (42)
Kentucky (10)
Louisiana (9)
Maine (12)
Maryland (305)
Massachusetts (1417)
Michigan (94)
Minnesota (138)
Missouri (24)
Montana (9)
Nebraska (12)
Nevada (29)
New Hampshire (14)
New Jersey (679)
New Mexico (16)
New York (684)
North Carolina (293)
North Dakota (2)
Northern California (846)
Ohio (61)
Oklahoma (5)
Oregon (22)
Pennsylvania (450)
Puerto Rico (5)
Rhode Island (10)
South America (656)
South Carolina (11)
South Dakota (1)
Southern California (737)
Tennessee (25)
Texas (246)
United States (7676)
Utah (54)
Virginia (58)
Washington D.C. (16)
Washington State (203)
West Virginia (2)
Wisconsin (21)
250,791 Results for "zambon group spa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Amneal Enters into Exclusive European Licensing Agreement with Zambon Biotech for IPX203
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”) today announced that it has entered into an exclusive licensing agreement with Zambon Biotech SA, part of the Zambon group (“Zambon”), for IPX203 in the European Union, United Kingdom, and Switzerland.
February 27, 2024
·
9 min read
Legal
Lilly’s Fight to Stop Zepbound Knockoffs Leads to Lawsuit Against Indianapolis Spa
Eli Lilly says Indianapolis-based Premier Weight Loss is cracking open auto-injector pens containing its blockbuster drug and repackaging them into separate doses.
April 7, 2025
·
4 min read
·
Annalee Armstrong
Press Releases
Zambon Taps Kinaxis to Enhance Transparency Across Global Supply Chain
September 23, 2024
·
3 min read
Press Releases
Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025
April 25, 2025
·
2 min read
Stevanato Group to Present at the Bank of America Securities Healthcare Conference
Stevanato Group S.p.A. announced that it will participate in the Bank of America Securities Healthcare Conference taking place from Tuesday, May 14, 2024 to Thursday, May 16, 2024.
May 1, 2024
·
1 min read
Business
Stevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco Moro
Stevanato Group S.p.A. announced today that its Board of Directors has appointed Franco Stevanato, a current director and the Executive Chairman of the Company, as its new Chief Executive Officer.
May 28, 2024
·
4 min read
Business
Stevanato Group appoints Ugo Gay as Chief Operations Officer
Stevanato Group S.p.A. today announced the appointment of Ugo Gay as its new Chief Operations Officer (COO).
April 4, 2024
·
4 min read
Stevanato Group to Present at Upcoming Investor Conferences - May 23, 2024
Stevanato Group S.p.A. announced today that it will participate in two upcoming investor conferences. The Company will present at the William Blair Growth Stock Conference in Chicago on Tuesday, June 4, 2024 at 4:00 p.m. (CT), and at the Jefferies Healthcare Conference in New York
May 23, 2024
·
1 min read
Business
Stevanato Group Reports Financial Results for the First Quarter of 2024
Stevanato Group S.p.A., a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced its financial results for the first quarter of 2024.
May 9, 2024
·
18 min read
Press Releases
Duchesnay Pharmaceutical Group creates Advisory Board to help guide the Group’s growth and success
April 16, 2025
·
5 min read
1 of 25,080
Next
